Stephen Keely

Stephen Keely is a dedicated researcher with a focus on chronic intestinal diseases such as irritable bowel syndrome, inflammatory bowel disease, and colon cancer, which pose significant challenges in terms of patient health and healthcare costs.

His work centers around the role of bile acids as regulatory hormones in intestinal functions and how they impact various gastrointestinal diseases, particularly inflammatory, diarrheal, and neoplastic conditions.

Stephen's research involves investigating the interaction between bile acids, intestinal microbiota, epithelial cell function, and immune responses, utilizing a range of scientific approaches including electrophysiology, molecular biology, imaging, and biochemistry.

His ultimate goal is to uncover novel therapeutic strategies targeting bile acids and their receptors for the management of intestinal diseases.

With a background in Epithelial Physiology, Electrophysiology, Molecular Biology, Imaging, and Biochemistry, Stephen Keely brings a wealth of expertise to his research endeavors.

He holds a PhD in Epithelial transport and a BSc in Pharmacology, both from University College Dublin.

Currently, he serves as the Assistant Director for Molecular Medicine at the Royal College of Surgeons in Ireland, showcasing his leadership and expertise in the field.

Stephen has also held positions as an Assistant Project Scientist and Visiting Postdoctoral Researcher at UC San Diego, further enriching his research experience and contributions to the scientific community.